About the Authors
- David A. White
-
Contributed equally to this work with: David A. White, Lu Fang
Affiliations Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia
- Lu Fang
-
Contributed equally to this work with: David A. White, Lu Fang
Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Australia
- William Chan
-
Affiliation Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia
- Eric F. Morand
-
Affiliation Centre for Inflammatory Diseases, Monash University, Melbourne, Australia
- Helen Kiriazis
-
Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Australia
- Stephen J. Duffy
-
Affiliations Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia
- Andrew J. Taylor
-
Affiliations Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia
- Anthony M. Dart
-
Affiliations Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia
- Xiao-Jun Du
-
* E-mail: xiaoming.gao@bakeridi.edu.au (X-MG); xiao-jun.du@bakeridi.edu.au (X-JD)
Affiliations Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia
- Xiao-Ming Gao
-
* E-mail: xiaoming.gao@bakeridi.edu.au (X-MG); xiao-jun.du@bakeridi.edu.au (X-JD)
Affiliations Baker IDI Heart and Diabetes Institute, Melbourne, Australia, Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia
Competing Interests
The authors have the following interests. The authors declare that although Cortical pharmaceutical company donated the anti-MIF compound, COR100140, it did not influence any part of this research. This study was partly funded by a postgraduate scholarship from GlaxoSmithKline Australia to WC. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: XMG XJD AMD. Performed the experiments: XMG DAW LF WC HK SJD AJT. Analyzed the data: XMG DAW LF WC HK SJD AJT. Contributed reagents/materials/analysis tools: EFM SJD AJT. Wrote the manuscript: XMG DAW XJD.